Levaxin

Levothyroxine, the active ingredient in Levaxin, is a thyroid hormone presented as an oral tablet for oral use. It replaces deficient endogenous thyroid hormone and is prescribed for patients with hypothyroidism, thyroid hormone deficiency, or goiter to restore normal metabolic function.

GNH USA supplies Levaxin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, sourcing the product from EU‑regulated manufacturers and adhering to stringent quality and regulatory standards. The product is distributed through GNH USA's global logistics network, ensuring reliable delivery to authorized healthcare providers.

Levaxin (levothyroxine) is used in thyroid hormone replacement therapy to address conditions characterized by insufficient endogenous hormone production. - Hypothyroidism: restores normal thyroid hormone levels, alleviating fatigue, weight gain, and cold intolerance. - Thyroid hormone deficiency: provides synthetic thyroxine to compensate for inadequate glandular output, supporting metabolic homeostasis. - Goiter: reduces thyroid‑stimulating hormone stimulation, helping to decrease gland enlargement.

Levaxin may cause adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Headache: mild to moderate head pain. - Insomnia: difficulty falling or staying asleep. - Palpitations: sensation of rapid or irregular heartbeat. - Weight loss: unintended reduction in body weight. - Heat intolerance: increased sensitivity to warm environments.

Serious or Rare Side Effects: - Cardiac arrhythmia: abnormal heart rhythm that may be life‑threatening. - Angina pectoris: chest pain due to reduced coronary blood flow. - Myocardial infarction: heart attack resulting from coronary artery blockage. - Severe allergic reaction: rash, swelling, or anaphylaxis requiring immediate medical attention.

When prescribing Levaxin, clinicians should consider several precautionary measures to ensure safe and effective therapy. - Dose titration: adjust dose gradually, especially in elderly patients, to avoid overtreatment. - Thyroid function monitoring: check serum TSH and free T4 levels regularly to maintain target range. - Cardiovascular disease: use caution in patients with ischemic heart disease or arrhythmias, as excess hormone may increase cardiac workload. - Adrenal insufficiency: ensure adequate glucocorticoid replacement before initiating therapy to prevent adrenal crisis. - Pregnancy and lactation: evaluate risk‑benefit ratio, as thyroid hormone requirements may change during pregnancy. - Store at ambient temperature: keep tablets below 25 °C in the original container, protected from moisture and light.

Levaxin can interact with various medicines, altering its absorption or systemic effects.

Major Interactions (Avoid): - Calcium supplements: bind levothyroxine in the gut, reducing its absorption. - Iron preparations: decrease levothyroxine bioavailability when taken concurrently. - Antacids containing aluminum or magnesium: impair absorption of levothyroxine. - Cholestyramine or colestipol: sequester levothyroxine, leading to subtherapeutic levels. - Sucralfate: forms complexes with levothyroxine, diminishing its effectiveness.

Moderate Interactions (Monitor Closely): - Warfarin: levothyroxine may enhance anticoagulant effect, requiring INR monitoring. - Oral contraceptives: may increase thyroxine binding proteins, affecting dose requirements. - Amiodarone: can alter thyroid hormone metabolism, necessitating closer thyroid function testing. - Carbamazepine or phenytoin: induce hepatic enzymes, potentially lowering levothyroxine levels. - Rifampin: accelerates levothyroxine clearance, possibly requiring dose adjustment.